For COVID-19 and vaccination updates, view our information for the community. If you're experiencing symptoms, call your primary care provider.
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
To study the genes of tumor cells to determine if these results will help physicians select the best treatment options for patients with genetic changes.
DiagnosisStage IB-IIIA Non-Small Cell Lung Cancer
Eastern Cooperative Oncology Group (ECOG) performance status 0-1
No prior chemotherapy or radiation therapy for this lung cancer
Patients must sign an approved informed consent and authorization permitting release of personal health information.
For more information, visit ClinicalTrials.gov